KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Paychex (PAYX) Cash & Equivalents (2016 - 2026)

Paychex (PAYX) has disclosed Cash & Equivalents for 18 consecutive years, with $1.7 billion as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents rose 11.43% to $1.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Feb 2026, up 11.43% year-over-year, with the annual reading at $1.6 billion for FY2025, 10.87% up from the prior year.
  • Cash & Equivalents hit $1.7 billion in Q1 2026 for Paychex, up from $1.5 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.7 billion in Q1 2026 to a low of $267.5 million in Q1 2022.
  • Historically, Cash & Equivalents has averaged $1.3 billion across 5 years, with a median of $1.4 billion in 2023.
  • Biggest five-year swings in Cash & Equivalents: plummeted 66.01% in 2022 and later skyrocketed 392.3% in 2023.
  • Year by year, Cash & Equivalents stood at $1.1 billion in 2022, then increased by 24.31% to $1.4 billion in 2023, then decreased by 11.81% to $1.2 billion in 2024, then increased by 23.58% to $1.5 billion in 2025, then rose by 17.29% to $1.7 billion in 2026.
  • Business Quant data shows Cash & Equivalents for PAYX at $1.7 billion in Q1 2026, $1.5 billion in Q4 2025, and $809.0 million in Q3 2025.